 |
PDBsum entry 6c0h
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Biosynthetic protein
|
PDB id
|
|
|
|
6c0h
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
114 a.a.
|
 |
|
|
|
|
|
|
|
108 a.a.
|
 |
|
|
|
|
|
|
|
14 a.a.
|
 |
|
|
|
|
|
|
|
|
|
|
|
References listed in PDB file
|
 |
|
Key reference
|
 |
|
Title
|
 |
Substrate-Assisted enzymatic formation of lysinoalanine in duramycin.
|
 |
|
Authors
|
 |
L.An,
D.P.Cogan,
C.D.Navo,
G.Jiménez-Osés,
S.K.Nair,
W.A.Van der donk.
|
 |
|
Ref.
|
 |
Nat Chem Biol, 2018,
14,
928-933.
[DOI no: ]
|
 |
|
PubMed id
|
 |
|
 |
 |
|
Abstract
|
 |
|
Duramycin is a heavily post-translationally modified peptide that binds
phosphatidylethanolamine. It has been investigated as an antibiotic, an
inhibitor of viral entry, a therapeutic for cystic fibrosis, and a tumor and
vasculature imaging agent. Duramycin contains a β-hydroxylated Asp (Hya) and
four macrocycles, including an essential lysinoalanine (Lal) cross-link. The
mechanism of Lal formation is not known. Here we show that Lal is installed
stereospecifically by DurN via addition of Lys19 to a dehydroalanine. The
structure of DurN reveals an unusual dimer with a new fold. Surprisingly, in the
structure of duramycin bound to DurN, no residues of the enzyme are near the Lal
cross-link. Instead, Hya15 of the substrate makes interactions with Lal,
suggesting it acts as a base to deprotonate Lys19 during catalysis. Biochemical
data suggest that DurN preorganizes the reactive conformation of the substrate,
such that the Hya15 of the substrate can serve as the catalytic base for Lal
formation.
|
 |
|
|
|
|
 |